New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 15, 2013
09:20 EDTACTV, PPC, RIG, WMT, LOGM, ELLI, JCP, A, BKW, QLIK, HLFOn The Fly: Pre-market Movers
HIGHER: Herablife (HLF), up 17.3% after Carl Icahn reports 12.98% stake, says company is a legitimate business and he intends to explore ways to enhance shareholder value... Neptune Technologies (NEPT), up 8.7% after initiation with Outperform rating, $6 target at JMP Securities... UP AFTER EARNINGS: Qlik Technologies (QLIK), up 18.6%... Ellie Mae (ELLI), up 14.9%... Pilgrim's Pride (PPC), up 8.9%... Burger King Worldwide (BKW), up 3.6%... DOWN AFTER EARNINGS: LogMeIn (LOGM), down 25.7%... Active Network (ACTV), down 9.9%... Agilent (A), down 3.5%... ALSO LOWER: Transocean (RIG), down 4% after downgrades at Deutsche Bank and Howard Weil, last night's fleet status report... J.C. Penney (JCP), down 3.7% after Credit Suisse says new credit agreement increases likelihood of a dilutive offering... Wal-Mart (WMT), down 1.9% after Cleveland Research says U.S. sales have slowed significantly in recent weeks.
News For HLF;JCP;RIG;QLIK;ELLI;PPC;BKW;LOGM;ACTV;A;WMT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 18, 2015
16:00 EDTRIGOptions Update; May 18, 2015
Subscribe for More Information
15:35 EDTWMTWal-Mart May 79.5 weekly straddle priced for 2.4% movement into Q1
Subscribe for More Information
15:15 EDTWMTWal-Mart May weekly volatility increases into Q1 and outlook
Subscribe for More Information
15:00 EDTWMTNotable companies reporting before tomorrow's open
Subscribe for More Information
15:00 EDTANotable companies reporting after market close
Subscribe for More Information
14:35 EDTWMTWal-Mart technical comments ahead of results
Subscribe for More Information
14:04 EDTWMTEarnings Watch: Wal-Mart sees Q1 EPS 95c-$1.10, U.S. SSS up 1%-2%
Subscribe for More Information
12:12 EDTHLFHerbalife dips after FTC says to announce 'major consumer fraud' case
Subscribe for More Information
11:15 EDTRIGStocks with call strike movement; CHK RIG
Subscribe for More Information
07:21 EDTWMTWal-Mart Q1 should benefit from lower gas, stronger consumer, says Stephens
Subscribe for More Information
06:30 EDTWMTWal-Mart to repair stores in labor dispute, Reuters reports
Wal-Mart said it would seek permits to rip up floors and replace plumping lines at five stores that justified its abrupt closure, reports Reuters. The move follows a union-backed complaint to the National Labor Relations Board last month after Wal-Mart temporarily closed the stores. The union accused the company for shutting down the stores to stop workers from organizing. Reference Link
May 15, 2015
17:33 EDTLOGMPoint72 Asset Management gives quarterly update on stakes
Subscribe for More Information
16:31 EDTRIGTransocean declares dividend of 60c per share
Subscribe for More Information
10:45 EDTRIGStocks with call strike movement; CHK RIG
Chesapeake (CHK) October 17 call option implied volatility increased 2% to 45, Transocean (RIG) August 21 call option implied volatility increased 4% to 42 according to IVolatility.
10:23 EDTELLIEllie Mae management to meet with Oppenheimer
Subscribe for More Information
10:01 EDTJCPOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Aspen Technology (AZPN) upgraded to Overweight from Sector Weight at Pacific Crest... Canadian National (CNI) upgraded to Outperform from Sector Perform at Scotia Capital... Connecticut Water (CTWS) upgraded to Outperform from Market Perform at Wells Fargo... Hanesbrands (HBI) upgraded to Buy from Neutral at DA Davidson... Impala Platinum (IMPUY) upgraded to Buy from Neutral at Goldman... Inovalon (INOV) upgraded to Buy from Neutral at Goldman... J.C. Penney (JCP) upgraded to Market Perform at BMO Capital... Sovran Self Storage (SSS) upgraded to Buy from Neutral at UBS... Syngenta (SYT) upgraded to Neutral from Underperform at Exane BNP Paribas... UPS (UPS) upgraded to Buy from Neutral at Goldman... Union Pacific (UNP) upgraded to Buy from Hold at TD Securities... Yum! Brands (YUM) upgraded to Overweight from Neutral at JPMorgan.
08:08 EDTADarwin Professional presents positive clinical data for ALD403
Alder BioPharmaceuticals announced that six-month follow-up data from its Phase 2 proof-of-concept clinical trial of ALD403, its anti-calcitonin gene-related peptide, or CGRP, antibody for the prevention of frequent episodic migraine, were presented in an oral presentation at the 17th Congress of the International Headache Society in Valencia, Spain. Key Points from Oral Session: Migraine Pathophysiology and CGRP as a Therapeutic Target: A single intravenous dose of ALD403 1000mg demonstrated prolonged efficacy over six months for the preventive treatment of migraine. Over three months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 61% vs 33%; 33% vs 9%; and 16% vs 0%, respectively. Over six months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 53% vs 28%; 26% vs 7%; and 11% vs 0%, respectively. ALD403 was well tolerated and there were no differences from placebo in terms of adverse events or laboratory safety data. The migraine prevention proof-of-concept trial was conducted in 163 patients with frequent episodic migraine who had on average nine headache days per month. Patients were given a single intravenous dose of 1000mg of ALD403 or placebo. The primary endpoint was the mean change in migraine headache days from baseline to weeks 5-8, and patients were followed for 24 weeks for additional safety and efficacy analyses.
07:14 EDTJCPJ.C. Penney upgraded to Market Perform at BMO Capital
Subscribe for More Information
07:05 EDTJCPJ.C. Penney upgraded to Market Perform from Underperform at BMO Capital
Subscribe for More Information
05:50 EDTRIGStocks with implied volatility movement; YOKU RIG
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use